2524 related articles for article (PubMed ID: 12945798)
41. Breast cancer and HRT--what are the data?
Bieber EJ; Barnes RB
Int J Fertil Womens Med; 2001; 46(2):73-8. PubMed ID: 11374658
[TBL] [Abstract][Full Text] [Related]
42. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
Rigby AJ; Ma J; Stafford RS
Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
[TBL] [Abstract][Full Text] [Related]
43. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
Schonberg MA; Wee CC
J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
[TBL] [Abstract][Full Text] [Related]
44. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
[TBL] [Abstract][Full Text] [Related]
45. Menopausal hormone therapy, hormone receptor status, and lung cancer in women.
Chlebowski RT
Semin Oncol; 2009 Dec; 36(6):566-71. PubMed ID: 19995648
[TBL] [Abstract][Full Text] [Related]
46. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
Aubuchon M; Santoro N
Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
[TBL] [Abstract][Full Text] [Related]
47. Pitfalls of the WHIs: Women's Health Initiative.
Mastorakos G; Sakkas EG; Xydakis AM; Creatsas G
Ann N Y Acad Sci; 2006 Dec; 1092():331-40. PubMed ID: 17308158
[TBL] [Abstract][Full Text] [Related]
48. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
49. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
Mikkola TS; Clarkson TB; Notelovitz M
Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
[TBL] [Abstract][Full Text] [Related]
50. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
51. A clinician's review of the WHI-related literature.
Speroff L
Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
[TBL] [Abstract][Full Text] [Related]
52. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
53. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
54. Menopausal hormone therapy: currently no evidence for cardiac protection.
Wenger NK
Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
[TBL] [Abstract][Full Text] [Related]
55. Hormone use and patient concerns after the findings of the Women's Health Initiative.
Rolnick SJ; Kopher RA; DeFor TA; Kelley ME
Menopause; 2005; 12(4):399-404. PubMed ID: 16037754
[TBL] [Abstract][Full Text] [Related]
56. [Present position of the hormonal replacement therapy].
Fait T; Vokrouhlická J; Vrablík M; Jenícek J
Cas Lek Cesk; 2004; 143(7):447-52. PubMed ID: 15373286
[TBL] [Abstract][Full Text] [Related]
57. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
58. [What is the actual lesson from the WHI study upon its completion?].
Pines A
Harefuah; 2004 Oct; 143(10):722-3, 766. PubMed ID: 15521348
[TBL] [Abstract][Full Text] [Related]
59. [Phytoestrogens--an alternative to hormonal replacement therapy].
Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
[TBL] [Abstract][Full Text] [Related]
60. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
Tan O; Harman SM; Naftolin F
Bull NYU Hosp Jt Dis; 2009; 67(2):226-9. PubMed ID: 19583558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
